首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1550586

去勢抗性前列腺癌市場：依治療類型、藥物類別、給藥途徑、通路及地區

Castrate Resistant Prostate Cancer Market, By Therapy Type, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2024年07月26日 | 出版商:

Coherent Market Insights | 英文 167 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球去勢抗性前列腺癌市場規模為98億美元，預計2031年將達175.1億美元，2024年至2031年複合年成長率為8.6%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	98億美元
實際資料	2019-2023	預測期	2024年至2031年
預測 2024-2031 年複合年成長率：	8.60%	2031年價值預測	175.1億美元

圖：2024 年去勢抗性前列腺癌市場佔有率（按地區分類）

全球去勢抗性前列腺癌市場的成長是由全球前列腺癌盛行率上升所推動的。攝護腺癌是男性最常見的癌症之一。根據2020年美國癌症協會資料，美國報告了約191,930例前列腺癌新病例。儘管透過藥物或手術治療降低睪固酮水平或阻止其作用，但當癌症擴散並開始生長時，它被稱為去勢抗性前列腺癌（CRPC）。目前CRPC可用的治療方法包括化療、免疫療法和放射線治療。然而，抗藥性的發展仍然是有效治療晚期前列腺癌的主要挑戰。對新藥物標靶和治療方法的持續研究可以克服抗治療性並改善 CRPC 患者的治療結果。

市場動態：

全球去勢抗性前列腺癌市場的成長是由更容易患前列腺癌的老齡化人口的增加所推動的。聯合國《2019年世界人口展望》資料顯示，65歲以上人口預計將從2019年的7.03億增加到2050年的15億。此外，意識的提高和篩檢率的提高加強了前列腺癌的早期檢測，推動了市場成長。然而，與免疫療法和標靶治療方案相關的高治療成本可能會阻礙市場成長。繼續研究和開發克服抗藥性的新機制可能為市場相關人員提供有希望的機會。開發負擔得起的生物相似藥可以降低治療成本。

本研究的主要特點

該報告對全球去勢抗性前列腺癌市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，了解全球去勢抗性前列腺癌市場的主要企業概況。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球去勢抗性前列腺癌市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球去勢抗性前列腺癌市場的各種策略矩陣，將有助於相關人員做出決策。

公司簡介
- Trelleborg Sealing Solutions
- Freudenberg Group
- Parker Hannifin Corp
- Saint-Gobain
- Bal Seal Engineering, Inc.
- Flexan
- Marco Rubber &Plastics
- Morgan Polymer Seals
- Minnesota Rubber and Plastics
- Precision Associates, Inc.
- IDEX Health &Science LLC
- Apple Rubber Products
- Technetics Group
- Sterne SAS
- ResMed
- West Pharmaceutical Services, Inc.

第11章分析師建議

命運之輪
分析師觀點
一致的機會圖

第12章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI4529

Global castrate resistant prostate cancer market is estimated to be valued at USD 9.80 Bn in 2024 and is expected to reach USD 17.51 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 9.80 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	8.60%	2031 Value Projection:	US$ 17.51 Bn

Figure. Castrate Resistant Prostate Cancer Market Share (%), By Region 2024

Castrate Resistant Prostate Cancer Market - IMG1

Global castrate resistant prostate cancer market growth is driven by rising prevalence of prostate cancer worldwide. Prostate cancer is one of the commonly occurring cancers among men. According to the data from American Cancer Society in 2020, around 191,930 new cases of prostate cancer were reported in the U.S. Once the cancer has metastasized and started growing despite medical or surgical therapy to reduce testosterone levels or block its action, it is termed as castrate resistant prostate cancer (CRPC). Currently available treatment options for CRPC include chemotherapy, immunotherapy, radiation therapy, and others. However, development of resistance remains a major challenge in effectively managing this advanced stage of prostate cancer. Ongoing research for novel drug targets and therapeutic approaches can overcome treatment resistance and improve patient outcomes in CRPC.

Market Dynamics:

Global castrate resistant prostate cancer market growth is driven by rising geriatric population susceptible to developing prostate cancer. According to the data from UN World Population Prospects 2019, the number of people aged 65 years or above is projected to grow from 703 million in 2019 to 1.5 billion in 2050 globally. Increasing awareness and screening rates have also augmented the early detection of prostate cancer, thus, driving the market growth. However, high treatment costs associated with immunotherapy and targeted therapy regimens can hamper the market growth. Ongoing research to develop novel mechanisms for overcoming drug resistance can offer promising opportunities for market players. Development of affordable biosimilars can reduce treatment costs.

Key Features of the Study:

This report provides in-depth analysis of the global castrate resistant prostate cancer market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global castrate resistant prostate cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Johnson & Johnson, Astellas Pharma, Sanofi, Dendreon, Bayer, and others
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global castrate resistant prostate cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global castrate resistant prostate cancer market

Detailed Segmentation-

By Therapy Type
- Hormonal Therapy
- Immunotherapy
- Chemotherapy
- Radiotherapy
By Drug Class
- Antineoplastic
- Non-steroidal Antiandrogen
- Corticosteroids
- Microtubule Inhibitor
- Others
By Route of Administration
- Oral
- Injectable
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Trelleborg Sealing Solutions
- Freudenberg Group
- Parker Hannifin Corp
- Saint-Gobain
- Bal Seal Engineering, Inc.
- Flexan
- Marco Rubber & Plastics
- Morgan Polymer Seals
- Minnesota Rubber and Plastics
- Precision Associates, Inc.
- IDEX Health & Science LLC
- Apple Rubber Products
- Technetics Group
- Sterne S.A.S.
- ResMed
- West Pharmaceutical Services, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Castrate Resistant Prostate Cancer Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Castrate Resistant Prostate Cancer Market, By Therapy Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hormonal Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Chemotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Radiotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Castrate Resistant Prostate Cancer Market, By Drug Class, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Antineoplastic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Non-steroidal Antiandrogen
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Microtubule Inhibitor
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Castrate Resistant Prostate Cancer Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Castrate Resistant Prostate Cancer Market, By Route of Administration, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Injectable
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Castrate Resistant Prostate Cancer Market, By Region, 2019 - 2031, (USDBn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profiles
- Trelleborg Sealing Solutions
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Freudenberg Group
- Parker Hannifin Corp
- Saint-Gobain
- Bal Seal Engineering, Inc.
- Flexan
- Marco Rubber & Plastics
- Morgan Polymer Seals
- Minnesota Rubber and Plastics
- Precision Associates, Inc.
- IDEX Health & Science LLC
- Apple Rubber Products
- Technetics Group
- Sterne S.A.S.
- ResMed
- West Pharmaceutical Services, Inc.